Literature DB >> 11264138

Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.

I A El-Ghrably1, H S Dua, G M Orr, D Fischer, P J Tighe.   

Abstract

AIM: To examine the contribution of infiltrating cells in the local production of cytokines within the vitreous of patients with proliferative vitreoretinopathy (PVR).
METHODS: The presence of mRNA coding for IL-6, IL-8, IL-1beta, IL-1alpha, TNFalpha, IFNgamma, IL-12, and HPRT was investigated in 25 vitreous samples from patients with PVR, 11 vitreous samples from patients with retinal detachment (RD) not complicated by PVR, and 10 vitreous samples from patients with macular hole (MH). A quantitative reverse transcriptase polymerase chain reaction (RT-PCR) using an internal competitor was used to investigate these samples. From these samples, 15 PVR, 8 RD, and 8 MH were analysed for the protein levels of the same cytokines using enzyme linked immunosorbent assay (ELISA). Spearman correlation was used to test any association between mRNA and cytokine protein levels, as an indicator of the contribution these cells make to the intravitreal cytokine milieu.
RESULTS: A strong correlation was found between mRNA and their respective cytokine levels (protein products) for IL-6, IL-8, IL-1beta, IL-1alpha, TNFalpha, IFNgamma (Spearman r = 0.83, 0.73, 0.67, 0.91, 0.73, and 0.73 respectively), but not for IL-12. The median levels of IL-6, IL-8, IL-1beta, and IFNgamma mRNA and their respective cytokines were significantly higher (p <0.05) in patients with PVR than in those with macular hole. There was no statistically significant difference in the median levels of IL-1alpha mRNA between PVR and MH but the cytokine IL-1alpha was detected at a significantly higher level in PVR compared with MH patients. Between PVR and RD patients, there was no statistically significant difference in mRNA levels for all the investigated cytokines (p >0.05) except for IL-6 where there was a statistical significance (p= 0.038). In contrast, the median levels of IL-6, IL-8, and IL-1beta cytokines were significantly higher (p <0.05) in patients with PVR than in those with RD, whereas for IL-1alpha and IFNgamma no significant statistical difference was detected between PVR and RD patients (p >0.05). When results of RD and MH patients were compared, a statistical difference was only detected in mRNA levels of INFgamma (p = 0.008). However, no difference was detected for INFgamma (protein product) or for any of the other cytokines between RD and MH patients.
CONCLUSION: Levels of both protein and mRNA encoding IL-6, IL-8, IL-1beta, and IFNgamma is significantly increased in vitreous samples from patients with PVR. The strong correlation between ELISA detectable cytokines (protein products) and their respective mRNA levels suggest that intravitreal, invasive cells are the major source of these cytokines, with the exception of IL-12. Cells invading the vitreous do not appear to locally produce IL-12 mRNA. This would appear to implicate cells peripheral to the vitreal mass as the major source of this cytokine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264138      PMCID: PMC1723908          DOI: 10.1136/bjo.85.4.461

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  42 in total

Review 1.  Pathogenic mechanisms in proliferative vitreoretinopathy.

Authors:  P A Campochiaro
Journal:  Arch Ophthalmol       Date:  1997-02

Review 2.  Risk factors for proliferative vitreoretinopathy.

Authors:  H Nagasaki; K Shinagawa
Journal:  Curr Opin Ophthalmol       Date:  1995-06       Impact factor: 3.761

Review 3.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

Review 4.  Proliferative vitreoretinopathy.

Authors:  E Chaum
Journal:  Int Ophthalmol Clin       Date:  1995

5.  Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells.

Authors:  G J Jaffe; W L Roberts; H L Wong; A D Yurochko; G J Cianciolo
Journal:  Exp Eye Res       Date:  1995-05       Impact factor: 3.467

6.  Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.

Authors:  S G Elner; V M Elner; G J Jaffe; A Stuart; S L Kunkel; R M Strieter
Journal:  Curr Eye Res       Date:  1995-11       Impact factor: 2.424

7.  Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy.

Authors:  G A Limb; A Alam; O Earley; W Green; A H Chignell; D C Dumonde
Journal:  Curr Eye Res       Date:  1994-11       Impact factor: 2.424

8.  Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.

Authors:  D J Kauffmann; J C van Meurs; D A Mertens; E Peperkamp; C Master; M E Gerritsen
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-03       Impact factor: 4.799

9.  Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; A G Limb; P J Ciclitira
Journal:  Scand J Gastroenterol       Date:  1995-05       Impact factor: 2.423

10.  Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.

Authors:  B Kenarova; L Voinov; C Apostolov; R Vladimirova; A Misheva
Journal:  Eur J Ophthalmol       Date:  1997 Jan-Mar       Impact factor: 1.922

View more
  26 in total

1.  Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells.

Authors:  J Troger; S Sellemond; G Kieselbach; M Kralinger; E Schmid; B Teuchner; Q A Nguyen; E Schretter-Irschick; W Göttinger
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 2.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

3.  Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways.

Authors:  Dan-Ning Hu; Mingchao Bi; David Y Zhang; Fei Ye; Steven A McCormick; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

4.  Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.

Authors:  Steven Pennock; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

5.  A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy.

Authors:  Steven Pennock; Marc-Andre Rheaume; Shizuo Mukai; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2011-10-28       Impact factor: 4.307

6.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

Review 7.  Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.

Authors:  Hetian Lei; Marc-Andre Rheaume; Andrius Kazlauskas
Journal:  Exp Eye Res       Date:  2009-11-25       Impact factor: 3.467

8.  Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Authors:  Tomomi Shitama; Hideyuki Hayashi; Sumiyo Noge; Eiichi Uchio; Kenji Oshima; Hisao Haniu; Nobuaki Takemori; Naoka Komori; Hiroyuki Matsumoto
Journal:  Proteomics Clin Appl       Date:  2008-09       Impact factor: 3.494

9.  Expression of TNF-alpha, IL-1beta, and IFN-gamma in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores.

Authors:  Ioannis K Petropoulos; Chrysoula V Vantzou; Fotini N Lamari; Nikolaos K Karamanos; Evangelos D Anastassiou; Nikolaos M Pharmakakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-17       Impact factor: 3.117

10.  Elevated proto-oncogene and collagen mRNA expression in PVR retinas.

Authors:  Margrit Hollborn; Frank Faude; Peter Wiedemann; Leon Kohen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.